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The search for an ideal mitral valve substitute continues.Ross1 described the use of a pulmonary autograft formitral valve replacement in 1967, and this operation isonly now being reappraised because of its many advan-
tages.2,3 In patients with irreparable mitral valvulopathy compli-
cated with chronic atrial fibrillation, addition of some sort of
ablative procedure has been recommended to make its benefits
more complete.4 Currently, a stentless bioprosthesis is accepted as
the right ventricular outflow tract (RVOT) substitute of choice in
the Ross procedure.4,5 We report on 2 patients who had satisfac-
tory results with the use of a Freestyle aortic root bioprosthesis
(Medtronic, Inc, Minneapolis, Minn) for RVOT reconstruction in
the Ross II procedure combined with the radiofrequency maze IV
procedure that was developed in our center.6,7
Clinical Summaries
PATIENT 1. A 48-year-old man with history of severe rheumatic
mitral stenosis, chronic atrial fibrillation, and left atrial thrombi
demonstrated by 2-dimensional echocardiography was referred to
us. He had just recovered from massive duodenal ulcer bleeding
and multiple cerebral hemorrhagic infarctions related to anticoag-
ulation therapy, complicated by acute respiratory failure 1 month
previously. Mechanical prostheses were apparently contraindi-
cated, whereas xenograft bioprostheses would be expected to de-
generate and calcify early because of the relatively young age of
the patient. The ablative procedure for the chronic atrial fibrillation
was another issue for this particular patient, as was avoidance of
lifelong anticoagulation.
The patient was operated on with the use of routine cardiopul-
monary bypass and antegrade oxygenated cold crystalloid cardio-
plegia. The mitral valve showed a fish-mouth appearance, with
rigid leaflets and completely fused subvalvular apparatus. The left
atrium was filled with thrombi and diffusely calcified. The pul-
monic valve was harvested and implanted inverted in the mitral
position inside a 26-mm Dacron polyester fabric tube as the “top
hat.”8 The RVOT was reestablished with a 27-mm Freestyle bio-
prosthesis and bovine pericardial patch reconstruction of the pos-
terior wall defect, which was created after the pulmonic valve
harvesting (Figure 1). The left atrial thromboendatriectomy and
radiofrequency maze IV procedure were done.
The patient recovered uneventfully and was discharged 10 days
after the operation in stable sinus rhythm. Follow-up transesoph-
ageal echocardiography 3 months after the operation confirmed the
competent pulmonary autograft in the mitral position without
pressure gradient. The patient has been drug free since then.
PATIENT 2. A 44-year-old woman with a history of progressive
shortness of breath and abdominal distention and atrial fibrillation
for 2 years. She had undergone percutaneous transluminal mitral
commissurotomy 9 years previously, with suboptimal results for
her severe rheumatic mitral stenosis. Repeated transthoracic echo-
cardiography revealed recurrent severe calcified mitral stenosis
and tricuspid regurgitation. Because of the patient’s age and her
refusal of permanent anticoagulation, we decided to use the pa-
tient’s own pulmonic valve.
The patient was operated on with the use of routine cardiopul-
monary bypass and antegrade oxygenated cold crystalloid cardio-
plegia. The mitral valve appearance was consistent with rheumatic
valvulopathy, with both leaflets severely thickened and calcified.
The anterolateral commissure was well split, but it was impossible
to repair the valve because of the thickened and fused subvalvular
apparatus. The top hat technique was used as previously described
for patient 1. The radiofrequency maze IV procedure and tricuspid
valve repair were also done.
The patient recovered uneventfully and was discharged 12 days
after surgery in stable sinus rhythm. Follow-up transesophageal
echocardiography 3 months after the operation showed trivial
pulmonary autograft regurgitation in the mitral position (Figure 2)
without pressure gradient. The patient has been drug free since that
time.
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Discussion
Mitral repair is preferable but not always feasible, especially for
patients with complex rheumatic valvulopathy. Valve replacement
with a mechanical prosthesis or bioprosthesis is not without draw-
backs. The search for an ideal mitral substitute continues. Ross1
described the use of a pulmonary autograft for mitral valve re-
placement in 1967, and this operation is now being reappraised
because of its many advantages.2,3 Autografts show excellent
longevity, have clear hemodynamic superiority, are infection re-
sistant, and do not necessitate anticoagulation. These characteris-
tics are attractive, even though the procedure is complex and
time-consuming. Although there have been several modifica-
tions,4,9 we prefer the top hat technique,8 because we believe that
the proximal pericardial collar fixation is important to prevent
instability or deformity in this fully flexible tubing graft. Whether
the pulmonic valve is restrained within a prosthetic tube graft
seems less important. Because the entire autograft is buried within
the left atrial wall, the role of the autograft sinuses must be not as
important as the autograft in the aortic position.
Currently, a pulmonary homograft is preferred worldwide as
the RVOT substitute in the Ross procedure. The lack of pulmonary
homograft limits the use of the pulmonary autograft in many parts
of the world. Recently, a stentless bioprosthesis has been accepted
as the RVOT substitute in the Ross procedure.4,5 In this report, we
demonstrate that the use of a Freestyle aortic root bioprosthesis for
RVOT reconstruction in the Ross II procedure is feasible with
satisfactory results, at least in the short term.
Pericardial patch reconstruction of the RVOT posterior wall
defect, which was created after the pulmonic valve harvesting, is a
minor technique for effective hemostasis. This modification also
plays an important role for the strong RVOT reconstruction.
Kabbani and coworkers4 have recommended that some sort of
ablative procedure be added to the Ross II procedure when treating
patients with chronic atrial fibrillation, to make the benefits of the
procedure more complete. The radiofrequency maze IV procedure,
which was developed in our center, has provided promising long-
term results. This procedure can be performed with less bleeding
than the classic Cox maze procedure, and it is both less time-
consuming and less technically demanding.6,7
Aortic valve replacement with the pulmonary autograft is a
promising option. In contrast, the use of the pulmonary autograft
in the mitral position has been mentioned only in limited
articles.1-4,8,9 Nevertheless, Ross and Kabbani8 have demonstrated
that the pulmonic valve could function well inverted in the mitral
position for as long as 14 years.
In conclusion, although the potential for growth is lost when the
pulmonary autograft is used as the top hat, many advantages, such
as the excellent longevity, clear hemodynamic superiority, infec-
tion resistance, and lack of anticoagulation needs, make the Ross
II procedure worthy of reappraisal. This is especially true when the
radiofrequency maze IV procedure is added to this operation in
patients with chronic atrial fibrillation. In such cases, the surgeon
may achieve a cure for these challenging patients.
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Figure 1. RVOT was reestablished with 27-mm Freestyle biopros-
thesis and bovine pericardial patch reconstruction of posterior
wall defect, which was created after pulmonic valve harvesting.
Figure 2. Follow-up transesophageal echocardiogram 3 months
after operation shows trivial pulmonary autograft regurgitation in
mitral position.
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